Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals

J. A. Schouten, M. E. J. L. Hulscher, J. W. M. van der Meer, R. P. T. M. Grol (Nijmegen, Netherlands)

Source: Annual Congress 2005 - Treatment of respiratory infections
Session: Treatment of respiratory infections
Session type: Thematic Poster Session
Number: 4049
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. A. Schouten, M. E. J. L. Hulscher, J. W. M. van der Meer, R. P. T. M. Grol (Nijmegen, Netherlands). Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals. Eur Respir J 2005; 26: Suppl. 49, 4049

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relevance of correct antibiotic choice in community-acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Antibiotic usage analysis for community-acquired pneumonia (CAP) treatment
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Source: Eur Respir J 2002; 20: 432-439
Year: 2002



Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008



Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Source: Eur Respir J 2008; 32: 139-146
Year: 2008



Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 733s
Year: 2006

Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005

The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007